Formulation, optimization, characterization and in-vitro drug release kinetics of atenolol loaded PLGA nanoparticles using 3 3 factorial design for oral delivery-Reference-Cited by-同舟云学术

Formulation, optimization, characterization and in-vitro drug release kinetics of atenolol loaded PLGA nanoparticles using 3 3 factorial design for oral delivery

Published:2016-08 Issue: Volume:5 Page:1-13
ISSN:2352-9245
Container-title:Materials Discovery
language:en
Short-container-title:Materials Discovery

Author:

Chourasiya Vibha,Bohrey Sarvesh,Pandey Archna

Publisher

Elsevier BV

Subject

General Materials Science,Information Systems

Reference35 articles.

1. Preparation and characterization of hybrid nanoparticles based on chitosan and poly(methacryloylglycylglycine);Ferri;J. Nanopart. Res.,2014

2. Factors influencing the physicochemical characteristics of cationic polymer-coated liposomes prepared by high-pressure homogenization;Chunga;Colloids Surf. A,2014

3. Streptomycin-loaded PLGA-alginate nanoparticles: preparation, characterization, and assessment;Asadi;Appl. Nanosci.,2014

4. Antitumor activity of sorafenibincorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) blockcopolymer;Kim;Nanoscale Res. Lett.,2012

5. Biodegradable polymeric nanoparticles as drug delivery devices;Soppimatha;J. Control. Release,2001

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation optimization and PK/PD evaluation of novel valsartan bilosomes enhancing transdermal drug delivery;Journal of Drug Delivery Science and Technology;2024-02

2. Synthesis of Tubular Hydroxyapatite and Its Application in Polycaprolactone Scaffold Materials;Journal of Functional Biomaterials;2024-01-14

3. A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics;European Journal of Pharmaceutical Sciences;2024-01

4. Drug Delivery Systems and Cardiovascular Disease;Application of Biomaterials in the Treatment of Cardiovascular Diseases;2024

5. Optimization of Lurasidone HCl-Loaded PLGA Nanoparticles for Intramuscular Delivery: Enhanced Bioavailability, Reduced Dosing Frequency, Pharmacokinetics, and Therapeutic Outcomes;ASSAY and Drug Development Technologies;2023-12-27